Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Celgene Corp (NASDAQ:CELG)

136.44
Delayed Data
As of 4:00pm ET
 -1.40 / -1.02%
Today’s Change
96.93
Today|||52-Week Range
138.93
+17.87%
Year-to-Date

Today’s Trading

Previous close137.84
Today’s open138.70
Day’s range135.86 - 138.90
Volume3,645,465
Average volume (3 months)3,744,097
Market cap$107.6B
Dividend yield--
Data as of 4:00pm ET, 07/25/2017

Growth & Valuation

Earnings growth (last year)+28.35%
Earnings growth (this year)+22.63%
Earnings growth (next 5 years)+20.06%
Revenue growth (last year)+22.70%
P/E ratio51.3
Price/Sales8.51
Price/Book16.26

Competitors

 Today’s
change
Today’s
% change
GSKGlaxoSmithKline-0.28-0.66%
ABBVAbbVie-1.39-1.88%
LLYEli Lilly and Co-2.55-3.01%
SNYSanofi+0.36+0.75%
Data as of 4:02pm ET, 07/25/2017

Financials

Next reporting dateJuly 27, 2017
EPS forecast (this quarter)$1.78
Annual revenue (last year)$10.9B
Annual profit (last year)$2.0B
Net profit margin18.30%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Mark J. Alles
President &
Chief Operating Officer
Scott Andrew Smith
Corporate headquarters
Summit, New Jersey

Forecasts